13D/13G Filings - Cell Source Inc. (CLCS)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-06-10
1:48 pm
Purchase
2009-02-28 13D Cell Source, Inc.
CLCS
SHIMRAT ITAMAR 1,925,004
5.700%
1,925,004increase
(New Position)
Filing
History
2021-04-20
6:05 pm
Purchase
2009-02-28 13D Cell Source, Inc.
CLCS
Soave Darlene 3,591,754
9.900%
3,591,754increase
(New Position)
Filing
History
2020-12-29
12:19 pm
Purchase
2019-08-13 13G Cell Source, Inc.
CLCS
REISNER YAIR 3,782,004
10.580%
3,782,004increase
(New Position)
Filing
History
2020-11-16
5:59 pm
Purchase
2020-11-01 13G Cell Source, Inc.
CLCS
Yeda Research & Development Co. Ltd. 3,155,348
9.700%
3,155,348increase
(New Position)
Filing
History